Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Ok, I Agree
Dec
01
2020
By The African Mirror
Novavax sees start of U.S. COVID-19 vaccine trial in coming weeks after second delay

Novavax sees start of U.S. COVID-19 vaccine trial in coming weeks after second delay

COVID-19
VACCINE maker Novavax Inc has pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks instead of November, the company has announced. It is the second time that Novavax, which already has a late-stage UK trial underway, has rescheduled the Phase 3 trial after first flagging an October start, hampered by issues in scaling up its manufacturing. Shares of the U.S.-based company, which lags behind larger rivals Pfizer Inc and Moderna Inc in their COVID-19 vaccine development timelines, fell 6% on the latest delay. Novavax plans…
Read More
Sep
10
2020
By The African Mirror
South African volunteers on AstraZeneca vaccine trial say not alarmed by pause

South African volunteers on AstraZeneca vaccine trial say not alarmed by pause

COVID-19
SOUTH African volunteers on AstraZeneca’s experimental coronavirus vaccine trial said they were not worried to hear the trial had been paused after a participant fell ill and they hoped to be part of a potential solution to the pandemic. The vaccine, developed with the University of Oxford, has been described by the World Health Organization as probably the world’s leading candidate and the most advanced in terms of development. Some 2,000 volunteers in South Africa are taking part in the trial which was paused globally on Tuesday after an unexplained illness in a participant. An independent committee will review safety…
Read More
Facebook
Twitter
Linkedin
Instagram